Security key
090655606
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)
CUSIP: 090655606
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 327,161
- Total 13F value
- $383,382
- Share change
- -69,469
- SEC-reported price per share
- $1.18
- Number of holders
- 13
- Value change
- -$98,280
- Number of buys
- 6
- Number of sells
- 7
- Shares outstanding
- 27,267,374
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
13
Top holders
10
BRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
BioRestorative Therapies, Inc. SEC filings
BioRestorative Therapies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 090655606
Recent filing periods:
Ownership snapshot
Top reported holders of BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lance Alstodt
Disclosed value leader
Lance Alstodt
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
3/4/5
13F
Lead comparable stake: 16%
13D/G row: Lance Alstodt
Showing 1-6 of 15 holder rows.
Quick read
Lance Alstodt leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lance Alstodt's linked filing trail.
Comparable ownership
Top 5
Lance Alstodt
16%
Francisco Silva
15%
CITADEL ADVISORS LLC
0.39%
VANGUARD GROUP INC
0.33%
GEODE CAPITAL MANAGEMENT, LLC
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lance Alstodt |
13D/G
3/4/5
ALSTODT LANCE · President, CEO, COB, Director, 10%+ Owner
|
16%
|
$2,201,520
1,236,809 shares
|
$0 | 14 Feb 2025 |
| Francisco Silva |
13D/G
3/4/5
Silva, Francisco · VP of Research and Development, Director
|
15%
|
$2,130,338
1,196,819 shares
|
$0 | 14 Feb 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.39%
|
$151,880
106,210 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.33%
|
$126,952
88,778 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.2%
|
$79,033
55,269 shares
|
— | 30 Sep 2025 |
| WEALTH ALLIANCE, LLC |
13F
Company
|
0.15%
|
$58,000
40,000 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
327,161
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
14
Q4 2025 holders
13
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend